Johnson & Johnson

تفاصيل التقرير

Position on Clinical Trial Data Transparency

At Johnson & Johnson Innovative Medicine (J&J IM), we believe transparency of clinical trial data
advances science and medicine and is in the best interest of the patients who use our pharmaceutical
products and the providers who prescribe them. As such, we support the overall principles of greater
clinical trial data transparency, including registration and disclosure of clinical trial results in external
registries, publication of results in peer-reviewed journals, sharing of clinical...
نوع التقرير
تقرير استدامة شامل
اللغة
الإنجليزية
السنة
٢٠٢٤
الصيغة
PDF
معايير التقرير: GRI ISSB UN SDG
تنزيل التقرير